Global AT1 Receptor Antagonists Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global AT1 Receptor Antagonists Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for AT1 Receptor Antagonists by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for AT1 Receptor Antagonists by Country/Region, 2017, 2022 & 2028

2.2 AT1 Receptor Antagonists Segment by Type

2.2.1 Valsartan

2.2.2 Telmisartan

2.2.3 Losartan

2.2.4 Irbesartan

2.2.5 Azilsartan

2.2.6 Olmesartan

2.3 AT1 Receptor Antagonists Sales by Type

2.3.1 Global AT1 Receptor Antagonists Sales Market Share by Type (2017-2022)

2.3.2 Global AT1 Receptor Antagonists Revenue and Market Share by Type (2017-2022)

2.3.3 Global AT1 Receptor Antagonists Sale Price by Type (2017-2022)

2.4 AT1 Receptor Antagonists Segment by Application

2.4.1 Hypertension

2.4.2 Cardiovascular Diseases

2.4.3 Kidney Diseases

2.4.4 Other

2.5 AT1 Receptor Antagonists Sales by Application

2.5.1 Global AT1 Receptor Antagonists Sale Market Share by Application (2017-2022)

2.5.2 Global AT1 Receptor Antagonists Revenue and Market Share by Application (2017-2022)

2.5.3 Global AT1 Receptor Antagonists Sale Price by Application (2017-2022)

3 Global AT1 Receptor Antagonists by Company

3.1 Global AT1 Receptor Antagonists Breakdown Data by Company

3.1.1 Global AT1 Receptor Antagonists Annual Sales by Company (2020-2022)

3.1.2 Global AT1 Receptor Antagonists Sales Market Share by Company (2020-2022)

3.2 Global AT1 Receptor Antagonists Annual Revenue by Company (2020-2022)

3.2.1 Global AT1 Receptor Antagonists Revenue by Company (2020-2022)

3.2.2 Global AT1 Receptor Antagonists Revenue Market Share by Company (2020-2022)

3.3 Global AT1 Receptor Antagonists Sale Price by Company

3.4 Key Manufacturers AT1 Receptor Antagonists Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers AT1 Receptor Antagonists Product Location Distribution

3.4.2 Players AT1 Receptor Antagonists Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for AT1 Receptor Antagonists by Geographic Region

4.1 World Historic AT1 Receptor Antagonists Market Size by Geographic Region (2017-2022)

4.1.1 Global AT1 Receptor Antagonists Annual Sales by Geographic Region (2017-2022)

4.1.2 Global AT1 Receptor Antagonists Annual Revenue by Geographic Region

4.2 World Historic AT1 Receptor Antagonists Market Size by Country/Region (2017-2022)

4.2.1 Global AT1 Receptor Antagonists Annual Sales by Country/Region (2017-2022)

4.2.2 Global AT1 Receptor Antagonists Annual Revenue by Country/Region

4.3 Americas AT1 Receptor Antagonists Sales Growth

4.4 APAC AT1 Receptor Antagonists Sales Growth

4.5 Europe AT1 Receptor Antagonists Sales Growth

4.6 Middle East & Africa AT1 Receptor Antagonists Sales Growth

5 Americas

5.1 Americas AT1 Receptor Antagonists Sales by Country

5.1.1 Americas AT1 Receptor Antagonists Sales by Country (2017-2022)

5.1.2 Americas AT1 Receptor Antagonists Revenue by Country (2017-2022)

5.2 Americas AT1 Receptor Antagonists Sales by Type

5.3 Americas AT1 Receptor Antagonists Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC AT1 Receptor Antagonists Sales by Region

6.1.1 APAC AT1 Receptor Antagonists Sales by Region (2017-2022)

6.1.2 APAC AT1 Receptor Antagonists Revenue by Region (2017-2022)

6.2 APAC AT1 Receptor Antagonists Sales by Type

6.3 APAC AT1 Receptor Antagonists Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe AT1 Receptor Antagonists by Country

7.1.1 Europe AT1 Receptor Antagonists Sales by Country (2017-2022)

7.1.2 Europe AT1 Receptor Antagonists Revenue by Country (2017-2022)

7.2 Europe AT1 Receptor Antagonists Sales by Type

7.3 Europe AT1 Receptor Antagonists Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa AT1 Receptor Antagonists by Country

8.1.1 Middle East & Africa AT1 Receptor Antagonists Sales by Country (2017-2022)

8.1.2 Middle East & Africa AT1 Receptor Antagonists Revenue by Country (2017-2022)

8.2 Middle East & Africa AT1 Receptor Antagonists Sales by Type

8.3 Middle East & Africa AT1 Receptor Antagonists Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of AT1 Receptor Antagonists

10.3 Manufacturing Process Analysis of AT1 Receptor Antagonists

10.4 Industry Chain Structure of AT1 Receptor Antagonists

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 AT1 Receptor Antagonists Distributors

11.3 AT1 Receptor Antagonists Customer

12 World Forecast Review for AT1 Receptor Antagonists by Geographic Region

12.1 Global AT1 Receptor Antagonists Market Size Forecast by Region

12.1.1 Global AT1 Receptor Antagonists Forecast by Region (2023-2028)

12.1.2 Global AT1 Receptor Antagonists Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global AT1 Receptor Antagonists Forecast by Type

12.7 Global AT1 Receptor Antagonists Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer AT1 Receptor Antagonists Product Offered

13.1.3 Pfizer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis AT1 Receptor Antagonists Product Offered

13.2.3 Novartis AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck AT1 Receptor Antagonists Product Offered

13.3.3 Merck AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Astra Zeneca

13.4.1 Astra Zeneca Company Information

13.4.2 Astra Zeneca AT1 Receptor Antagonists Product Offered

13.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Astra Zeneca Main Business Overview

13.4.5 Astra Zeneca Latest Developments

13.5 Jhonson and Johnson

13.5.1 Jhonson and Johnson Company Information

13.5.2 Jhonson and Johnson AT1 Receptor Antagonists Product Offered

13.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Jhonson and Johnson Main Business Overview

13.5.5 Jhonson and Johnson Latest Developments

13.6 Eli Lilly

13.6.1 Eli Lilly Company Information

13.6.2 Eli Lilly AT1 Receptor Antagonists Product Offered

13.6.3 Eli Lilly AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly Main Business Overview

13.6.5 Eli Lilly Latest Developments

13.7 Sanofi

13.7.1 Sanofi Company Information

13.7.2 Sanofi AT1 Receptor Antagonists Product Offered

13.7.3 Sanofi AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanofi Main Business Overview

13.7.5 Sanofi Latest Developments

13.8 Bristol-Myers Squibb

13.8.1 Bristol-Myers Squibb Company Information

13.8.2 Bristol-Myers Squibb AT1 Receptor Antagonists Product Offered

13.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bristol-Myers Squibb Main Business Overview

13.8.5 Bristol-Myers Squibb Latest Developments

13.9 Bayer

13.9.1 Bayer Company Information

13.9.2 Bayer AT1 Receptor Antagonists Product Offered

13.9.3 Bayer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bayer Main Business Overview

13.9.5 Bayer Latest Developments

13.10 GSK

13.10.1 GSK Company Information

13.10.2 GSK AT1 Receptor Antagonists Product Offered

13.10.3 GSK AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 GSK Main Business Overview

13.10.5 GSK Latest Developments

13.11 Teva Pharmaceutical

13.11.1 Teva Pharmaceutical Company Information

13.11.2 Teva Pharmaceutical AT1 Receptor Antagonists Product Offered

13.11.3 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Teva Pharmaceutical Main Business Overview

13.11.5 Teva Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. AT1 Receptor Antagonists Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. AT1 Receptor Antagonists Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Valsartan

Table 4. Major Players of Telmisartan

Table 5. Major Players of Losartan

Table 6. Major Players of Irbesartan

Table 7. Major Players of Azilsartan

Table 8. Major Players of Olmesartan

Table 9. Global AT1 Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 10. Global AT1 Receptor Antagonists Sales Market Share by Type (2017-2022)

Table 11. Global AT1 Receptor Antagonists Revenue by Type (2017-2022) & ($ million)

Table 12. Global AT1 Receptor Antagonists Revenue Market Share by Type (2017-2022)

Table 13. Global AT1 Receptor Antagonists Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global AT1 Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 15. Global AT1 Receptor Antagonists Sales Market Share by Application (2017-2022)

Table 16. Global AT1 Receptor Antagonists Revenue by Application (2017-2022)

Table 17. Global AT1 Receptor Antagonists Revenue Market Share by Application (2017-2022)

Table 18. Global AT1 Receptor Antagonists Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global AT1 Receptor Antagonists Sales by Company (2020-2022) & (K Units)

Table 20. Global AT1 Receptor Antagonists Sales Market Share by Company (2020-2022)

Table 21. Global AT1 Receptor Antagonists Revenue by Company (2020-2022) ($ Millions)

Table 22. Global AT1 Receptor Antagonists Revenue Market Share by Company (2020-2022)

Table 23. Global AT1 Receptor Antagonists Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers AT1 Receptor Antagonists Producing Area Distribution and Sales Area

Table 25. Players AT1 Receptor Antagonists Products Offered

Table 26. AT1 Receptor Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global AT1 Receptor Antagonists Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global AT1 Receptor Antagonists Sales Market Share Geographic Region (2017-2022)

Table 31. Global AT1 Receptor Antagonists Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global AT1 Receptor Antagonists Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global AT1 Receptor Antagonists Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global AT1 Receptor Antagonists Sales Market Share by Country/Region (2017-2022)

Table 35. Global AT1 Receptor Antagonists Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global AT1 Receptor Antagonists Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas AT1 Receptor Antagonists Sales by Country (2017-2022) & (K Units)

Table 38. Americas AT1 Receptor Antagonists Sales Market Share by Country (2017-2022)

Table 39. Americas AT1 Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas AT1 Receptor Antagonists Revenue Market Share by Country (2017-2022)

Table 41. Americas AT1 Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 42. Americas AT1 Receptor Antagonists Sales Market Share by Type (2017-2022)

Table 43. Americas AT1 Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 44. Americas AT1 Receptor Antagonists Sales Market Share by Application (2017-2022)

Table 45. APAC AT1 Receptor Antagonists Sales by Region (2017-2022) & (K Units)

Table 46. APAC AT1 Receptor Antagonists Sales Market Share by Region (2017-2022)

Table 47. APAC AT1 Receptor Antagonists Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC AT1 Receptor Antagonists Revenue Market Share by Region (2017-2022)

Table 49. APAC AT1 Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 50. APAC AT1 Receptor Antagonists Sales Market Share by Type (2017-2022)

Table 51. APAC AT1 Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 52. APAC AT1 Receptor Antagonists Sales Market Share by Application (2017-2022)

Table 53. Europe AT1 Receptor Antagonists Sales by Country (2017-2022) & (K Units)

Table 54. Europe AT1 Receptor Antagonists Sales Market Share by Country (2017-2022)

Table 55. Europe AT1 Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe AT1 Receptor Antagonists Revenue Market Share by Country (2017-2022)

Table 57. Europe AT1 Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 58. Europe AT1 Receptor Antagonists Sales Market Share by Type (2017-2022)

Table 59. Europe AT1 Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 60. Europe AT1 Receptor Antagonists Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa AT1 Receptor Antagonists Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa AT1 Receptor Antagonists Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa AT1 Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa AT1 Receptor Antagonists Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa AT1 Receptor Antagonists Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa AT1 Receptor Antagonists Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa AT1 Receptor Antagonists Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa AT1 Receptor Antagonists Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of AT1 Receptor Antagonists

Table 70. Key Market Challenges & Risks of AT1 Receptor Antagonists

Table 71. Key Industry Trends of AT1 Receptor Antagonists

Table 72. AT1 Receptor Antagonists Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. AT1 Receptor Antagonists Distributors List

Table 75. AT1 Receptor Antagonists Customer List

Table 76. Global AT1 Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global AT1 Receptor Antagonists Sales Market Forecast by Region

Table 78. Global AT1 Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global AT1 Receptor Antagonists Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas AT1 Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas AT1 Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC AT1 Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC AT1 Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe AT1 Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe AT1 Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa AT1 Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa AT1 Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global AT1 Receptor Antagonists Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global AT1 Receptor Antagonists Sales Market Share Forecast by Type (2023-2028)

Table 90. Global AT1 Receptor Antagonists Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global AT1 Receptor Antagonists Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global AT1 Receptor Antagonists Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global AT1 Receptor Antagonists Sales Market Share Forecast by Application (2023-2028)

Table 94. Global AT1 Receptor Antagonists Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global AT1 Receptor Antagonists Revenue Market Share Forecast by Application (2023-2028)

Table 96. Pfizer Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 97. Pfizer AT1 Receptor Antagonists Product Offered

Table 98. Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. Pfizer Main Business

Table 100. Pfizer Latest Developments

Table 101. Novartis Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 102. Novartis AT1 Receptor Antagonists Product Offered

Table 103. Novartis AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Novartis Main Business

Table 105. Novartis Latest Developments

Table 106. Merck Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 107. Merck AT1 Receptor Antagonists Product Offered

Table 108. Merck AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. Merck Main Business

Table 110. Merck Latest Developments

Table 111. Astra Zeneca Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 112. Astra Zeneca AT1 Receptor Antagonists Product Offered

Table 113. Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 114. Astra Zeneca Main Business

Table 115. Astra Zeneca Latest Developments

Table 116. Jhonson and Johnson Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 117. Jhonson and Johnson AT1 Receptor Antagonists Product Offered

Table 118. Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 119. Jhonson and Johnson Main Business

Table 120. Jhonson and Johnson Latest Developments

Table 121. Eli Lilly Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 122. Eli Lilly AT1 Receptor Antagonists Product Offered

Table 123. Eli Lilly AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 124. Eli Lilly Main Business

Table 125. Eli Lilly Latest Developments

Table 126. Sanofi Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 127. Sanofi AT1 Receptor Antagonists Product Offered

Table 128. Sanofi AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 129. Sanofi Main Business

Table 130. Sanofi Latest Developments

Table 131. Bristol-Myers Squibb Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 132. Bristol-Myers Squibb AT1 Receptor Antagonists Product Offered

Table 133. Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 134. Bristol-Myers Squibb Main Business

Table 135. Bristol-Myers Squibb Latest Developments

Table 136. Bayer Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 137. Bayer AT1 Receptor Antagonists Product Offered

Table 138. Bayer AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 139. Bayer Main Business

Table 140. Bayer Latest Developments

Table 141. GSK Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 142. GSK AT1 Receptor Antagonists Product Offered

Table 143. GSK AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 144. GSK Main Business

Table 145. GSK Latest Developments

Table 146. Teva Pharmaceutical Basic Information, AT1 Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors

Table 147. Teva Pharmaceutical AT1 Receptor Antagonists Product Offered

Table 148. Teva Pharmaceutical AT1 Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 149. Teva Pharmaceutical Main Business

Table 150. Teva Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of AT1 Receptor Antagonists

Figure 2. AT1 Receptor Antagonists Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global AT1 Receptor Antagonists Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global AT1 Receptor Antagonists Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. AT1 Receptor Antagonists Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Valsartan

Figure 10. Product Picture of Telmisartan

Figure 11. Product Picture of Losartan

Figure 12. Product Picture of Irbesartan

Figure 13. Product Picture of Azilsartan

Figure 14. Product Picture of Olmesartan

Figure 15. Global AT1 Receptor Antagonists Sales Market Share by Type in 2021

Figure 16. Global AT1 Receptor Antagonists Revenue Market Share by Type (2017-2022)

Figure 17. AT1 Receptor Antagonists Consumed in Hypertension

Figure 18. Global AT1 Receptor Antagonists Market: Hypertension (2017-2022) & (K Units)

Figure 19. AT1 Receptor Antagonists Consumed in Cardiovascular Diseases

Figure 20. Global AT1 Receptor Antagonists Market: Cardiovascular Diseases (2017-2022) & (K Units)

Figure 21. AT1 Receptor Antagonists Consumed in Kidney Diseases

Figure 22. Global AT1 Receptor Antagonists Market: Kidney Diseases (2017-2022) & (K Units)

Figure 23. AT1 Receptor Antagonists Consumed in Other

Figure 24. Global AT1 Receptor Antagonists Market: Other (2017-2022) & (K Units)

Figure 25. Global AT1 Receptor Antagonists Sales Market Share by Application (2017-2022)

Figure 26. Global AT1 Receptor Antagonists Revenue Market Share by Application in 2021

Figure 27. AT1 Receptor Antagonists Revenue Market by Company in 2021 ($ Million)

Figure 28. Global AT1 Receptor Antagonists Revenue Market Share by Company in 2021

Figure 29. Global AT1 Receptor Antagonists Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global AT1 Receptor Antagonists Revenue Market Share by Geographic Region in 2021

Figure 31. Global AT1 Receptor Antagonists Sales Market Share by Region (2017-2022)

Figure 32. Global AT1 Receptor Antagonists Revenue Market Share by Country/Region in 2021

Figure 33. Americas AT1 Receptor Antagonists Sales 2017-2022 (K Units)

Figure 34. Americas AT1 Receptor Antagonists Revenue 2017-2022 ($ Millions)

Figure 35. APAC AT1 Receptor Antagonists Sales 2017-2022 (K Units)

Figure 36. APAC AT1 Receptor Antagonists Revenue 2017-2022 ($ Millions)

Figure 37. Europe AT1 Receptor Antagonists Sales 2017-2022 (K Units)

Figure 38. Europe AT1 Receptor Antagonists Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa AT1 Receptor Antagonists Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa AT1 Receptor Antagonists Revenue 2017-2022 ($ Millions)

Figure 41. Americas AT1 Receptor Antagonists Sales Market Share by Country in 2021

Figure 42. Americas AT1 Receptor Antagonists Revenue Market Share by Country in 2021

Figure 43. United States AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC AT1 Receptor Antagonists Sales Market Share by Region in 2021

Figure 48. APAC AT1 Receptor Antagonists Revenue Market Share by Regions in 2021

Figure 49. China AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 53. India AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe AT1 Receptor Antagonists Sales Market Share by Country in 2021

Figure 56. Europe AT1 Receptor Antagonists Revenue Market Share by Country in 2021

Figure 57. Germany AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 58. France AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa AT1 Receptor Antagonists Sales Market Share by Country in 2021

Figure 63. Middle East & Africa AT1 Receptor Antagonists Revenue Market Share by Country in 2021

Figure 64. Egypt AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country AT1 Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of AT1 Receptor Antagonists in 2021

Figure 70. Manufacturing Process Analysis of AT1 Receptor Antagonists

Figure 71. Industry Chain Structure of AT1 Receptor Antagonists

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles